Skip to content
value.today
Wave Life Sciences Pte Ltd logo

Wave Life Sciences Pte Ltd

Total raised
$78 M
2 rounds on record
Latest round
$66 M
Aug 2015
First round on record
Jan 2015
Today
Went public
See the company page

Wave Life Sciences Pte Ltd is listed today as Wave Life Sciences Ltd.: market value, financials and filings are on its company page.

Funding rounds

2 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Wave Life Sciences Pte Ltd
MonthRaisedRaiseSizeInvestorsSoldFiling
Aug 2015$66 MNo. 2$50 to $250 million

Wave Life Sciences Pte Ltd: Raise no. 2, Aug 2015

Investors in this round

19 investors had bought by the notice of Aug 28, 2015: 19 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 4 investors are named for Wave Life Sciences Pte Ltd as a whole in other filings: see Investors below.

What the notice says

Amount sold
$66 M of $66 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
$2,796,106
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Singapore

People named in the notice

  • Paul B. Bolno, M.D. · Executive Officer, Director
  • Tan Ping Ping · Executive Officer
  • Gregory L. Verdine · Director
  • Ken L. Takanashi · Director
  • Koji L. Miura · Director
  • Masaharu L. Tanaka · Director
  • Peter L. Kolchinsky · Director
  • Takeshi L. Wada · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • Leerink Partners LLC (CRD 39011) · Boston, MassachusettsSold in all US states

Signed by Kyle Moran, Vice President, Head of Finance. Source: SEC Form D, newest notice filed Aug 28, 2015. Read the notice at the SEC.

equitySEC
Jan 2015$12 MNo. 1$10 to $50 million

Wave Life Sciences Pte Ltd: Raise no. 1, Jan 2015

Investors in this round

2 investors had bought by the notice of Feb 2, 2015: 2 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 4 investors are named for Wave Life Sciences Pte Ltd as a whole in other filings: see Investors below.

What the notice says

Amount sold
$12 M of $12 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Singapore

People named in the notice

  • Paul B. Bolno, M.D. · Executive Officer, Director
  • Tan Ping Ping · Executive Officer
  • Gregory L. Verdine · Director
  • Ken L. Takanashi · Director
  • Koji L. Miura · Director
  • Masaharu L. Tanaka · Director
  • Peter L. Kolchinsky · Director
  • Takeshi L. Wada · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Paul B. Bolno, M.D., President & CEO. Source: SEC Form D, newest notice filed Feb 2, 2015. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Wave Life Sciences Pte Ltd chose not to state its revenue in its newest notice of a funding round (Aug 2015).

    SEC Form D · Aug 2015

  • The industry group it chose in its notices: Other Health Care.

    SEC Form D · Aug 2015

That is all the official record says: Wave Life Sciences Pte Ltd has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services of Wave Life Sciences Pte Ltd are on record.

Investors#

4 named in official filings. Open an investor to see everything it has backed.

Investors in Wave Life Sciences Pte Ltd
InvestorKindAmountRoundRoleSource
Kagoshima Shinsangyo Sousei Investment Limited PartnershipFund or asset managernot statednot statedHeld Series B preferred stock, 10% owner (Form 3, 2015)SEC Form 3
RA Capital Healthcare Fund LPFund or asset managernot statednot statedHeld Series B preferred stock, 10% owner, director (Form 3, 2015)SEC Form 3
Ra Capital Management, L.P.Fund or asset managernot statednot statedHeld Series B preferred stock, 10% owner, director (Form 3, 2015)SEC Form 3
Shin Nippon Biomedical Laboratories, Ltd.Companynot statednot statedHeld Series A and B preferred stock, 10% owner (Form 3, 2015)SEC Form 3

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 2 rounds above had up to 19 investors.

Largest shareholders today

Institutions holding Wave Life Sciences Ltd. shares, as of Sep 30, 2026.

Source: SEC Form 13F holdings reports · as of Sep 30, 2026. Value held and share of the company. All holders are on the company page.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Wave Life Sciences Pte Ltd
NameRoleNamed in
Paul B. Bolno, M.D.Executive officerAug 2015
Tan Ping PingExecutive officerAug 2015
Gregory L. VerdineDirectorAug 2015
Ken L. TakanashiDirectorAug 2015
Koji L. MiuraDirectorAug 2015
Masaharu L. TanakaDirectorAug 2015
Paul B. Bolno, M.D.DirectorAug 2015
Peter L. KolchinskyDirectorAug 2015
Takeshi L. WadaDirectorAug 2015

About

Biotechnology company.

Went public since 2015. Its SEC number is that of a company listed on a stock exchange.